BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kudo O, Sabokbar A, Pocock A, Itonaga I, Fujikawa Y, Athanasou N. Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism. Bone 2003;32:1-7. [DOI: 10.1016/s8756-3282(02)00915-8] [Cited by in Crossref: 312] [Cited by in F6Publishing: 126] [Article Influence: 17.3] [Reference Citation Analysis]
Number Citing Articles
1 Shao B, Fu X, Yu Y, Yang D. Regulatory effects of miRNA‑181a on FasL expression in bone marrow mesenchymal stem cells and its effect on CD4+T lymphocyte apoptosis in estrogen deficiency‑induced osteoporosis. Mol Med Rep 2018;18:920-30. [PMID: 29845202 DOI: 10.3892/mmr.2018.9026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
2 Park H, Noh AL, Kang JH, Sim JS, Lee DS, Yim M. Peroxiredoxin II negatively regulates lipopolysaccharide-induced osteoclast formation and bone loss via JNK and STAT3. Antioxid Redox Signal 2015;22:63-77. [PMID: 25074339 DOI: 10.1089/ars.2013.5748] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
3 Yeo L, Lom H, Juarez M, Snow M, Buckley CD, Filer A, Raza K, Scheel-Toellner D. Expression of FcRL4 defines a pro-inflammatory, RANKL-producing B cell subset in rheumatoid arthritis. Ann Rheum Dis 2015;74:928-35. [PMID: 24431391 DOI: 10.1136/annrheumdis-2013-204116] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 7.0] [Reference Citation Analysis]
4 Ganesh BB, Bhattacharya P, Gopisetty A, Sheng J, Vasu C, Prabhakar BS. IL-1β promotes TGF-β1 and IL-2 dependent Foxp3 expression in regulatory T cells. PLoS One 2011;6:e21949. [PMID: 21779356 DOI: 10.1371/journal.pone.0021949] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
5 Ponzetti M, Rucci N. Updates on Osteoimmunology: What's New on the Cross-Talk Between Bone and Immune System. Front Endocrinol (Lausanne) 2019;10:236. [PMID: 31057482 DOI: 10.3389/fendo.2019.00236] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 25.0] [Reference Citation Analysis]
6 Blair HC, Zaidi M. Osteoclastic differentiation and function regulated by old and new pathways. Rev Endocr Metab Disord 2006;7:23-32. [PMID: 17115268 DOI: 10.1007/s11154-006-9010-4] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 3.6] [Reference Citation Analysis]
7 Jung S, Yang HY, Lee TH. Differential expression of immunologic proteins in gingiva after socket preservation in mini pigs. J Appl Oral Sci 2015;23:187-95. [PMID: 26018311 DOI: 10.1590/1678-775720140311] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
8 Mabilleau G, Petrova NL, Edmonds ME, Sabokbar A. Increased osteoclastic activity in acute Charcot's osteoarthropathy: the role of receptor activator of nuclear factor-kappaB ligand. Diabetologia. 2008;51:1035-1040. [PMID: 18389210 DOI: 10.1007/s00125-008-0992-1] [Cited by in Crossref: 94] [Cited by in F6Publishing: 75] [Article Influence: 7.2] [Reference Citation Analysis]
9 Kadlub N, Sessiecq Q, Mandavit M, L'Hermine AC, Badoual C, Galmiche L, Berdal A, Descroix V, Picard A, Coudert AE. Molecular and cellular characterizations of human cherubism: disease aggressiveness depends on osteoclast differentiation. Orphanet J Rare Dis 2018;13:166. [PMID: 30236129 DOI: 10.1186/s13023-018-0907-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
10 Aarvold A, Smith JO, Tayton ER, Edwards CJ, Fowler DJ, Gent ED, Oreffo RO. The role of osteoblast cells in the pathogenesis of unicameral bone cysts. J Child Orthop 2012;6:339-46. [PMID: 23904902 DOI: 10.1007/s11832-012-0419-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
11 Ha YJ, Choi YS, Oh YR, Kang EH, Khang G, Park YB, Lee YJ. Fucoxanthin Suppresses Osteoclastogenesis via Modulation of MAP Kinase and Nrf2 Signaling. Mar Drugs 2021;19:132. [PMID: 33673704 DOI: 10.3390/md19030132] [Reference Citation Analysis]
12 Sevenoaks MJ, Stockley RA. Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity--a common inflammatory phenotype? Respir Res 2006;7:70. [PMID: 16669999 DOI: 10.1186/1465-9921-7-70] [Cited by in Crossref: 132] [Cited by in F6Publishing: 113] [Article Influence: 8.8] [Reference Citation Analysis]
13 Ilesanmi-Oyelere BL, Schollum L, Kuhn-Sherlock B, McConnell M, Mros S, Coad J, Roy NC, Kruger MC. Inflammatory markers and bone health in postmenopausal women: a cross-sectional overview. Immun Ageing 2019;16:15. [PMID: 31333751 DOI: 10.1186/s12979-019-0155-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
14 Ragipoglu D, Dudeck A, Haffner-Luntzer M, Voss M, Kroner J, Ignatius A, Fischer V. The Role of Mast Cells in Bone Metabolism and Bone Disorders. Front Immunol 2020;11:163. [PMID: 32117297 DOI: 10.3389/fimmu.2020.00163] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 12.0] [Reference Citation Analysis]
15 Hedvičáková V, Žižková R, Buzgo M, Rampichová M, Filová E. The Effect of Alendronate on Osteoclastogenesis in Different Combinations of M-CSF and RANKL Growth Factors. Biomolecules 2021;11:438. [PMID: 33809737 DOI: 10.3390/biom11030438] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Chin KY, Wan Ngah WZ, Ima-Nirwana S. Lessons from the Bone Chapter of the Malaysian Aging Men Study. Int J Environ Res Public Health 2016;13:E531. [PMID: 27231930 DOI: 10.3390/ijerph13060531] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
17 Blanco P, Palucka AK, Pascual V, Banchereau J. Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine Growth Factor Rev 2008;19:41-52. [PMID: 18258476 DOI: 10.1016/j.cytogfr.2007.10.004] [Cited by in Crossref: 292] [Cited by in F6Publishing: 281] [Article Influence: 22.5] [Reference Citation Analysis]
18 Yang L, Xing R, Li C, Liu Y, Sun L, Liu X, Wang Y. Active immunization with Tocilizumab mimotopes induces specific immune responses. BMC Biotechnol 2015;15:46. [PMID: 26033236 DOI: 10.1186/s12896-015-0161-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
19 Amarasekara DS, Yun H, Kim S, Lee N, Kim H, Rho J. Regulation of Osteoclast Differentiation by Cytokine Networks. Immune Netw 2018;18:e8. [PMID: 29503739 DOI: 10.4110/in.2018.18.e8] [Cited by in Crossref: 126] [Cited by in F6Publishing: 118] [Article Influence: 42.0] [Reference Citation Analysis]
20 Zhou X, Cao H, Yuan Y, Wu W. Biochemical Signals Mediate the Crosstalk between Cartilage and Bone in Osteoarthritis. Biomed Res Int 2020;2020:5720360. [PMID: 32337258 DOI: 10.1155/2020/5720360] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
21 Wagoner KL, Bader RA. Evaluation of SV40-transformed synovial fibroblasts in the study of rheumatoid arthritis pathogenesis. Rheumatol Int 2012;32:1885-91. [PMID: 21445545 DOI: 10.1007/s00296-011-1913-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
22 Steffen U, Schett G, Bozec A. How Autoantibodies Regulate Osteoclast Induced Bone Loss in Rheumatoid Arthritis. Front Immunol 2019;10:1483. [PMID: 31333647 DOI: 10.3389/fimmu.2019.01483] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 13.0] [Reference Citation Analysis]
23 Feng W, Liu H, Luo T, Liu D, Du J, Sun J, Wang W, Han X, Yang K, Guo J, Amizuka N, Li M. Combination of IL-6 and sIL-6R differentially regulate varying levels of RANKL-induced osteoclastogenesis through NF-κB, ERK and JNK signaling pathways. Sci Rep 2017;7:41411. [PMID: 28128332 DOI: 10.1038/srep41411] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 7.8] [Reference Citation Analysis]
24 Schröder A, Bauer K, Spanier G, Proff P, Wolf M, Kirschneck C. Expression kinetics of human periodontal ligament fibroblasts in the early phases of orthodontic tooth movement. J Orofac Orthop 2018;79:337-51. [PMID: 30019109 DOI: 10.1007/s00056-018-0145-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 10.7] [Reference Citation Analysis]
25 Yoo M, Cho S, Shin S, Kim JM, Park HG, Cho S, Hwang YK, Park DH. Therapeutic Effect of IL1β Priming Tonsil Derived-Mesenchymal Stem Cells in Osteoporosis. Tissue Eng Regen Med 2021. [PMID: 34115339 DOI: 10.1007/s13770-021-00350-3] [Reference Citation Analysis]
26 Lon HK, DuBois DC, Earp JC, Almon RR, Jusko WJ. Modeling effects of dexamethasone on disease progression of bone mineral density in collagen-induced arthritic rats. Pharmacol Res Perspect 2015;3:e00169. [PMID: 26516581 DOI: 10.1002/prp2.169] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
27 Weller EB, Weller RA, Kloos AL, Hitchcock S, Kim WJ, Zemel B. Impact of depression and its treatment on the bones of growing children. Curr Psychiatry Rep 2007;9:94-8. [PMID: 17389117 DOI: 10.1007/s11920-007-0077-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
28 Lee JH, Kim HN, Yang D, Jung K, Kim HM, Kim HH, Ha H, Lee ZH. Trolox prevents osteoclastogenesis by suppressing RANKL expression and signaling. J Biol Chem 2009;284:13725-34. [PMID: 19299513 DOI: 10.1074/jbc.M806941200] [Cited by in Crossref: 53] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
29 He B, Zhang ZK, Liu J, He YX, Tang T, Li J, Guo BS, Lu AP, Zhang BT, Zhang G. Bioinformatics and Microarray Analysis of miRNAs in Aged Female Mice Model Implied New Molecular Mechanisms for Impaired Fracture Healing. Int J Mol Sci 2016;17:E1260. [PMID: 27527150 DOI: 10.3390/ijms17081260] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
30 Chen L, Cheng S, Sun K, Wang J, Liu X, Zhao Y, Yang J, Zhao D, Xue C, Tao Y, Zhao S, Zhang H, Lu S, Shi Q, Wang Y, Shu B. Changes in macrophage and inflammatory cytokine expressions during fracture healing in an ovariectomized mice model. BMC Musculoskelet Disord 2021;22:494. [PMID: 34049522 DOI: 10.1186/s12891-021-04360-z] [Reference Citation Analysis]
31 Xu S, De Veirman K, De Becker A, Vanderkerken K, Van Riet I. Mesenchymal stem cells in multiple myeloma: a therapeutical tool or target? Leukemia 2018;32:1500-14. [PMID: 29535427 DOI: 10.1038/s41375-018-0061-9] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 13.0] [Reference Citation Analysis]
32 Lucci A, Krishnamurthy S, Singh B, Bedrosian I, Meric-Bernstam F, Reuben J, Broglio K, Mosalpuria K, Lodhi A, Vincent L, Cristofanilli M. Cyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrow. Breast Cancer Res Treat 2009;117:61-8. [PMID: 18663571 DOI: 10.1007/s10549-008-0135-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
33 Jann J, Gascon S, Roux S, Faucheux N. Influence of the TGF-β Superfamily on Osteoclasts/Osteoblasts Balance in Physiological and Pathological Bone Conditions. Int J Mol Sci 2020;21:E7597. [PMID: 33066607 DOI: 10.3390/ijms21207597] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
34 Kozak M, Dabrowska-Zamojcin E, Mazurek-Mochol M, Pawlik A. Cytokines and Their Genetic Polymorphisms Related to Periodontal Disease. J Clin Med 2020;9:E4045. [PMID: 33327639 DOI: 10.3390/jcm9124045] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
35 Bastidas-Coral AP, Hogervorst JMA, Forouzanfar T, Kleverlaan CJ, Koolwijk P, Klein-Nulend J, Bakker AD. IL-6 counteracts the inhibitory effect of IL-4 on osteogenic differentiation of human adipose stem cells. J Cell Physiol 2019;234:20520-32. [PMID: 31016754 DOI: 10.1002/jcp.28652] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
36 Korkosz M, Czepiel M, Guła Z, Stec M, Węglarczyk K, Rutkowska-Zapała M, Gruca A, Lenart M, Baran J, Gąsowski J, Błyszczuk P, Siedlar M. Sera of patients with axial spondyloarthritis (axSpA) enhance osteoclastogenic potential of monocytes isolated from healthy individuals. BMC Musculoskelet Disord 2018;19:434. [PMID: 30522483 DOI: 10.1186/s12891-018-2356-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
37 Kollmann K, Pestka JM, Kühn SC, Schöne E, Schweizer M, Karkmann K, Otomo T, Catala-Lehnen P, Failla AV, Marshall RP, Krause M, Santer R, Amling M, Braulke T, Schinke T. Decreased bone formation and increased osteoclastogenesis cause bone loss in mucolipidosis II. EMBO Mol Med 2013;5:1871-86. [PMID: 24127423 DOI: 10.1002/emmm.201302979] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
38 Battafarano G, Rossi M, Marampon F, Del Fattore A. Cellular and Molecular Mediators of Bone Metastatic Lesions. Int J Mol Sci 2018;19:E1709. [PMID: 29890702 DOI: 10.3390/ijms19061709] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
39 Zupan J, Komadina R, Marc J. The relationship between osteoclastogenic and anti-osteoclastogenic pro-inflammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues. J Biomed Sci 2012;19:28. [PMID: 22380539 DOI: 10.1186/1423-0127-19-28] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 3.6] [Reference Citation Analysis]
40 Hennigan S, Kavanaugh A. Interleukin-6 inhibitors in the treatment of rheumatoid arthritis. Ther Clin Risk Manag 2008;4:767-75. [PMID: 19209259 DOI: 10.2147/tcrm.s3470] [Cited by in Crossref: 54] [Cited by in F6Publishing: 38] [Article Influence: 5.4] [Reference Citation Analysis]
41 Wang Y, Pivonka P, Buenzli PR, Smith DW, Dunstan CR. Computational modeling of interactions between multiple myeloma and the bone microenvironment. PLoS One 2011;6:e27494. [PMID: 22110661 DOI: 10.1371/journal.pone.0027494] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
42 Xiao L, Xiao Y. The Autophagy in Osteoimmonology: Self-Eating, Maintenance, and Beyond. Front Endocrinol (Lausanne) 2019;10:490. [PMID: 31428045 DOI: 10.3389/fendo.2019.00490] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
43 Yang X, Ricciardi BF, Hernandez-Soria A, Shi Y, Pleshko Camacho N, Bostrom MP. Callus mineralization and maturation are delayed during fracture healing in interleukin-6 knockout mice. Bone 2007;41:928-36. [PMID: 17921078 DOI: 10.1016/j.bone.2007.07.022] [Cited by in Crossref: 196] [Cited by in F6Publishing: 176] [Article Influence: 14.0] [Reference Citation Analysis]
44 Wang M, Xia F, Wei Y, Wei X. Molecular mechanisms and clinical management of cancer bone metastasis. Bone Res 2020;8:30. [PMID: 34321455 DOI: 10.1038/s41413-020-00105-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 18.0] [Reference Citation Analysis]
45 Yoon Y, Khan IU, Choi KU, Jung T, Jo K, Lee SH, Kim WH, Kim DY, Kweon OK. Different Bone Healing Effects of Undifferentiated and Osteogenic Differentiated Mesenchymal Stromal Cell Sheets in Canine Radial Fracture Model. Tissue Eng Regen Med 2018;15:115-24. [PMID: 30603539 DOI: 10.1007/s13770-017-0092-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
46 Lokau J, Schoeder V, Garbers C. [The role of interleukin-11 in osteosarcoma]. Pathologe 2020;41:163-7. [PMID: 32078699 DOI: 10.1007/s00292-020-00756-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
47 Silver JS, Hunter CA. gp130 at the nexus of inflammation, autoimmunity, and cancer. J Leukoc Biol. 2010;88:1145-1156. [PMID: 20610800 DOI: 10.1189/jlb.0410217] [Cited by in Crossref: 159] [Cited by in F6Publishing: 155] [Article Influence: 14.5] [Reference Citation Analysis]
48 Kirschneck C, Küchler EC, Wolf M, Spanier G, Proff P, Schröder A. Effects of the Highly COX-2-Selective Analgesic NSAID Etoricoxib on Human Periodontal Ligament Fibroblasts during Compressive Orthodontic Mechanical Strain. Mediators Inflamm 2019;2019:2514956. [PMID: 30983880 DOI: 10.1155/2019/2514956] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
49 Jonitz-Heincke A, Tillmann J, Klinder A, Krueger S, Kretzer JP, Høl PJ, Paulus AC, Bader R. The Impact of Metal Ion Exposure on the Cellular Behavior of Human Osteoblasts and PBMCs: In Vitro Analyses of Osteolytic Processes. Materials (Basel) 2017;10:E734. [PMID: 28773099 DOI: 10.3390/ma10070734] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
50 Bondar C, Ormazabal M, Crivaro A, Ferreyra-Compagnucci M, Delpino MV, Rozenfeld PA, Mucci JM. Osteocyte Alterations Induce Osteoclastogenesis in an In Vitro Model of Gaucher Disease. Int J Mol Sci 2017;18:E112. [PMID: 28098793 DOI: 10.3390/ijms18010112] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
51 Sabokbar A, Mahoney DJ, Hemingway F, Athanasou NA. Non-Canonical (RANKL-Independent) Pathways of Osteoclast Differentiation and Their Role in Musculoskeletal Diseases. Clin Rev Allergy Immunol. 2016;51:16-26. [PMID: 26578261 DOI: 10.1007/s12016-015-8523-6] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 9.8] [Reference Citation Analysis]
52 Bhagavatham SKS, Khanchandani P, Kannan V, Potikuri D, Sridharan D, Pulukool SK, Naik AA, Dandamudi RB, Divi SM, Pargaonkar A, Ray R, Santha SSR, Seshagiri PB, Narasimhan K, Gumdal N, Sivaramakrishnan V. Adenosine deaminase modulates metabolic remodeling and orchestrates joint destruction in rheumatoid arthritis. Sci Rep 2021;11:15129. [PMID: 34301999 DOI: 10.1038/s41598-021-94607-5] [Reference Citation Analysis]
53 Amiable N, Tat SK, Lajeunesse D, Duval N, Pelletier JP, Martel-Pelletier J, Boileau C. Proteinase-activated receptor (PAR)-2 activation impacts bone resorptive properties of human osteoarthritic subchondral bone osteoblasts. Bone 2009;44:1143-50. [PMID: 19264156 DOI: 10.1016/j.bone.2009.02.015] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
54 Oh JH, Lee NK. Up-Regulation of RANK Expression via ERK1/2 by Insulin Contributes to the Enhancement of Osteoclast Differentiation. Mol Cells 2017;40:371-7. [PMID: 28535663 DOI: 10.14348/molcells.2017.0025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
55 Schwerd T, Krause F, Twigg SRF, Aschenbrenner D, Chen YH, Borgmeyer U, Müller M, Manrique S, Schumacher N, Wall SA, Jung J, Damm T, Glüer CC, Scheller J, Rose-John S, Jones EY, Laurence A, Wilkie AOM, Schmidt-Arras D, Uhlig HH. A variant in IL6ST with a selective IL-11 signaling defect in human and mouse. Bone Res 2020;8:24. [PMID: 34112760 DOI: 10.1038/s41413-020-0098-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
56 Horenstein AL, Bracci C, Morandi F, Malavasi F. CD38 in Adenosinergic Pathways and Metabolic Re-programming in Human Multiple Myeloma Cells: In-tandem Insights From Basic Science to Therapy. Front Immunol 2019;10:760. [PMID: 31068926 DOI: 10.3389/fimmu.2019.00760] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 14.5] [Reference Citation Analysis]
57 Allard-Chamard H, Carrier N, Dufort P, Durand M, de Brum-Fernandes AJ, Boire G, Komarova SV, Dixon SJ, Harrison RE, Manolson MF, Roux S. Osteoclasts and their circulating precursors in rheumatoid arthritis: Relationships with disease activity and bone erosions. Bone Rep 2020;12:100282. [PMID: 32478145 DOI: 10.1016/j.bonr.2020.100282] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
58 Boyapati A, Msihid J, Fiore S, van Adelsberg J, Graham NM, Hamilton JD. Sarilumab plus methotrexate suppresses circulating biomarkers of bone resorption and synovial damage in patients with rheumatoid arthritis and inadequate response to methotrexate: a biomarker study of MOBILITY. Arthritis Res Ther 2016;18:225. [PMID: 27716324 DOI: 10.1186/s13075-016-1132-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 5.6] [Reference Citation Analysis]
59 Fajar JK, Azharuddin A. The association between interleukin 6 -174 G/C gene polymorphism and the risk of osteoporosis: A meta-analysis. J Taibah Univ Med Sci 2017;12:212-20. [PMID: 31435242 DOI: 10.1016/j.jtumed.2016.07.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
60 Westermann LM, Baranowsky A, Di Lorenzo G, Danyukova T, Soul J, Schwartz JM, Hendrickx G, Amling M, Rose-John S, Garbers C, Schinke T, Pohl S. Transgenic inhibition of interleukin-6 trans-signaling does not prevent skeletal pathologies in mucolipidosis type II mice. Sci Rep 2021;11:3556. [PMID: 33574442 DOI: 10.1038/s41598-021-82802-3] [Reference Citation Analysis]
61 Kiuru M, Solomon J, Ghali B, van der Meulen M, Crystal RG, Hidaka C. Transient overexpression of sonic hedgehog alters the architecture and mechanical properties of trabecular bone. J Bone Miner Res 2009;24:1598-607. [PMID: 19338448 DOI: 10.1359/jbmr.090313] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
62 Lü Q, Gou Y, Tian F, Zhang L. [Research progress on protease-activated receptor 2 in pathogenesis of osteoarthritis]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2017;31:1517-22. [PMID: 29806398 DOI: 10.7507/1002-1892.201705025] [Reference Citation Analysis]
63 Pagnotti GM, Styner M, Uzer G, Patel VS, Wright LE, Ness KK, Guise TA, Rubin J, Rubin CT. Combating osteoporosis and obesity with exercise: leveraging cell mechanosensitivity. Nat Rev Endocrinol 2019;15:339-55. [PMID: 30814687 DOI: 10.1038/s41574-019-0170-1] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 27.5] [Reference Citation Analysis]
64 Kitaura H, Marahleh A, Ohori F, Noguchi T, Shen WR, Qi J, Nara Y, Pramusita A, Kinjo R, Mizoguchi I. Osteocyte-Related Cytokines Regulate Osteoclast Formation and Bone Resorption. Int J Mol Sci 2020;21:E5169. [PMID: 32708317 DOI: 10.3390/ijms21145169] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 19.0] [Reference Citation Analysis]
65 Numan MS, Amiable N, Brown JP, Michou L. Paget's disease of bone: an osteoimmunological disorder? Drug Des Devel Ther 2015;9:4695-707. [PMID: 26316708 DOI: 10.2147/DDDT.S88845] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
66 Zupan J, Jeras M, Marc J. Osteoimmunology and the influence of pro-inflammatory cytokines on osteoclasts. Biochem Med (Zagreb) 2013;23:43-63. [PMID: 23457765 DOI: 10.11613/bm.2013.007] [Cited by in Crossref: 82] [Cited by in F6Publishing: 45] [Article Influence: 10.3] [Reference Citation Analysis]
67 Braux J, Velard F, Guillaume C, Jourdain ML, Gangloff SC, Jallot E, Nedelec JM, Laquerrière P, Laurent-Maquin D. Strontium-Substituted Bioceramics Particles: A New Way to Modulate MCP-1 and Gro-α Production by Human Primary Osteoblastic Cells. Materials (Basel) 2016;9:E985. [PMID: 28774105 DOI: 10.3390/ma9120985] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
68 Ng B, Widjaja AA, Viswanathan S, Dong J, Chothani SP, Lim S, Shekeran SG, Tan J, McGregor NE, Walker EC, Sims NA, Schafer S, Cook SA. Similarities and differences between IL11 and IL11RA1 knockout mice for lung fibro-inflammation, fertility and craniosynostosis. Sci Rep 2021;11:14088. [PMID: 34239012 DOI: 10.1038/s41598-021-93623-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
69 Ding ZC, Lin YK, Gan YK, Tang TT. Molecular pathogenesis of fracture nonunion. J Orthop Translat 2018;14:45-56. [PMID: 30035032 DOI: 10.1016/j.jot.2018.05.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
70 Zorina O, Amkhadova M, Khamukova A, Aleskerov E, Ajrapetov G, Demidova A. Osteoimmunological aspects of periodontal inflammatory destructive changes at periimplantitis, chronic periodontitis and oncological diseases of the oral cavity. Stomat 2020;99:27. [DOI: 10.17116/stomat20209904127] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
71 Ito H, Yamada H, Shibata TN, Mitomi H, Nomoto S, Ozaki S. Dual role of interleukin-17 in pannus growth and osteoclastogenesis in rheumatoid arthritis. Arthritis Res Ther 2011;13:R14. [PMID: 21294864 DOI: 10.1186/ar3238] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
72 Xiao L, Zhou Y, Friis T, Beagley K, Xiao Y. S1P-S1PR1 Signaling: the "Sphinx" in Osteoimmunology. Front Immunol 2019;10:1409. [PMID: 31293578 DOI: 10.3389/fimmu.2019.01409] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
73 Saito H, Gasser A, Bolamperti S, Maeda M, Matthies L, Jähn K, Long CL, Schlüter H, Kwiatkowski M, Saini V, Pajevic PD, Bellido T, van Wijnen AJ, Mohammad KS, Guise TA, Taipaleenmäki H, Hesse E. TG-interacting factor 1 (Tgif1)-deficiency attenuates bone remodeling and blunts the anabolic response to parathyroid hormone. Nat Commun 2019;10:1354. [PMID: 30902975 DOI: 10.1038/s41467-019-08778-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
74 Clément-Demange L, Mulcrone PL, Tabarestani TQ, Sterling JA, Elefteriou F. β2ARs stimulation in osteoblasts promotes breast cancer cell adhesion to bone marrow endothelial cells in an IL-1β and selectin-dependent manner. J Bone Oncol 2018;13:1-10. [PMID: 30245970 DOI: 10.1016/j.jbo.2018.09.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
75 Bastidas-Coral AP, Bakker AD, Kleverlaan CJ, Hogervorst JMA, Klein-Nulend J, Forouzanfar T. Polymethyl methacrylate does not adversely affect the osteogenic potential of human adipose stem cells or primary osteoblasts. J Biomed Mater Res B Appl Biomater 2020;108:1536-45. [PMID: 31648414 DOI: 10.1002/jbm.b.34501] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
76 Liu H, Gu R, Zhu Y, Lian X, Wang S, Liu X, Ping Z, Liu Y, Zhou Y. D-mannose attenuates bone loss in mice via Treg cell proliferation and gut microbiota-dependent anti-inflammatory effects. Ther Adv Chronic Dis 2020;11:2040622320912661. [PMID: 32341776 DOI: 10.1177/2040622320912661] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
77 Paine A, Ritchlin C. Altered Bone Remodeling in Psoriatic Disease: New Insights and Future Directions. Calcif Tissue Int 2018;102:559-74. [PMID: 29330560 DOI: 10.1007/s00223-017-0380-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
78 Moon SJ, Ahn IE, Jung H, Yi H, Kim J, Kim Y, Kwok SK, Park KS, Min JK, Park SH, Kim HY, Ju JH. Temporal differential effects of proinflammatory cytokines on osteoclastogenesis. Int J Mol Med 2013;31:769-77. [PMID: 23403591 DOI: 10.3892/ijmm.2013.1269] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
79 Ching K, Houard X, Berenbaum F, Wen C. Hypertension meets osteoarthritis - revisiting the vascular aetiology hypothesis. Nat Rev Rheumatol 2021;17:533-49. [PMID: 34316066 DOI: 10.1038/s41584-021-00650-x] [Reference Citation Analysis]
80 Mizutani K, Sud S, Pienta KJ. Prostate cancer promotes CD11b positive cells to differentiate into osteoclasts. J Cell Biochem 2009;106:563-9. [PMID: 19170075 DOI: 10.1002/jcb.22021] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
81 Lau YS, Sabokbar A, Giele H, Cerundolo V, Hofstetter W, Athanasou NA. Malignant melanoma and bone resorption. Br J Cancer 2006;94:1496-503. [PMID: 16641914 DOI: 10.1038/sj.bjc.6603103] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
82 Suva LJ, Washam C, Nicholas RW, Griffin RJ. Bone metastasis: mechanisms and therapeutic opportunities. Nat Rev Endocrinol 2011;7:208-18. [PMID: 21200394 DOI: 10.1038/nrendo.2010.227] [Cited by in Crossref: 231] [Cited by in F6Publishing: 206] [Article Influence: 23.1] [Reference Citation Analysis]
83 Morley JE, Kim MJ, Haren MT. Frailty and hormones. Rev Endocr Metab Disord 2005;6:101-8. [PMID: 15843881 DOI: 10.1007/s11154-005-6722-9] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 3.2] [Reference Citation Analysis]
84 Cai WL, Huang WD, Li B, Chen TR, Li ZX, Zhao CL, Li HY, Wu YM, Yan WJ, Xiao JR. microRNA-124 inhibits bone metastasis of breast cancer by repressing Interleukin-11. Mol Cancer 2018;17:9. [PMID: 29343249 DOI: 10.1186/s12943-017-0746-0] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 14.3] [Reference Citation Analysis]
85 Hu W, Chen Y, Dou C, Dong S. Microenvironment in subchondral bone: predominant regulator for the treatment of osteoarthritis. Ann Rheum Dis 2020:annrheumdis-2020-218089. [PMID: 33158879 DOI: 10.1136/annrheumdis-2020-218089] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
86 Zdzisińska B, Bojarska-Junak A, Dmoszyńska A, Kandefer-Szerszeń M. Abnormal cytokine production by bone marrow stromal cells of multiple myeloma patients in response to RPMI8226 myeloma cells. Arch Immunol Ther Exp (Warsz) 2008;56:207-21. [PMID: 18512025 DOI: 10.1007/s00005-008-0022-5] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 3.1] [Reference Citation Analysis]
87 Phalke SP, Chiplunkar SV. Activation status of γδ T cells dictates their effect on osteoclast generation and bone resorption. Bone Rep 2015;3:95-103. [PMID: 28377972 DOI: 10.1016/j.bonr.2015.10.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
88 Bon J, Fuhrman CR, Weissfeld JL, Duncan SR, Branch RA, Chang CC, Zhang Y, Leader JK, Gur D, Greenspan SL, Sciurba FC. Radiographic emphysema predicts low bone mineral density in a tobacco-exposed cohort. Am J Respir Crit Care Med 2011;183:885-90. [PMID: 20935108 DOI: 10.1164/rccm.201004-0666OC] [Cited by in Crossref: 89] [Cited by in F6Publishing: 45] [Article Influence: 8.1] [Reference Citation Analysis]
89 Madel MB, Elefteriou F. Mechanisms Supporting the Use of Beta-Blockers for the Management of Breast Cancer Bone Metastasis. Cancers (Basel) 2021;13:2887. [PMID: 34207620 DOI: 10.3390/cancers13122887] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Sansone V, Pagani D, Melato M. The effects on bone cells of metal ions released from orthopaedic implants. A review. Clin Cases Miner Bone Metab. 2013;10:34-40. [PMID: 23858309 DOI: 10.11138/ccmbm/2013.10.1.034] [Cited by in Crossref: 46] [Cited by in F6Publishing: 60] [Article Influence: 5.8] [Reference Citation Analysis]
91 Steger GG, Bartsch R. Denosumab for the treatment of bone metastases in breast cancer: evidence and opinion. Ther Adv Med Oncol 2011;3:233-43. [PMID: 21957430 DOI: 10.1177/1758834011412656] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
92 Zhang D, Huang Y, Huang Z, Zhang R, Wang H, Huang D. FTY-720P Suppresses Osteoclast Formation by Regulating Expression of Interleukin-6 (IL-6), Interleukin-4 (IL-4), and Matrix Metalloproteinase 2 (MMP-2). Med Sci Monit 2016;22:2187-94. [PMID: 27344392 DOI: 10.12659/msm.896690] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
93 Kearns AE, Khosla S, Kostenuik PJ. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr Rev. 2008;29:155-192. [PMID: 18057140 DOI: 10.1210/er.2007-0014] [Cited by in Crossref: 502] [Cited by in F6Publishing: 425] [Article Influence: 35.9] [Reference Citation Analysis]
94 Shupp AB, Kolb AD, Mukhopadhyay D, Bussard KM. Cancer Metastases to Bone: Concepts, Mechanisms, and Interactions with Bone Osteoblasts. Cancers (Basel) 2018;10:E182. [PMID: 29867053 DOI: 10.3390/cancers10060182] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 14.7] [Reference Citation Analysis]
95 Giorello MB, Matas A, Marenco P, Davies KM, Borzone FR, Calcagno ML, García-Rivello H, Wernicke A, Martinez LM, Labovsky V, Chasseing NA. CD1a- and CD83-positive dendritic cells as prognostic markers of metastasis development in early breast cancer patients. Breast Cancer 2021. [PMID: 34240315 DOI: 10.1007/s12282-021-01270-9] [Reference Citation Analysis]
96 Ogawa K, Mawatari M, Komine M, Shigematsu M, Kitajima M, Kukita A, Hotokebuchi T. Mature and activated osteoclasts exist in the synovium of rapidly destructive coxarthrosis. J Bone Miner Metab 2007;25:354-60. [PMID: 17968487 DOI: 10.1007/s00774-007-0761-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
97 Dickerson TJ, Suzuki E, Stanecki C, Shin HS, Qui H, Adamopoulos IE. Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6. J Autoimmun 2012;39:369-76. [PMID: 22867712 DOI: 10.1016/j.jaut.2012.06.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
98 Göbel A, Dell'Endice S, Jaschke N, Pählig S, Shahid A, Hofbauer LC, Rachner TD. The Role of Inflammation in Breast and Prostate Cancer Metastasis to Bone. Int J Mol Sci 2021;22:5078. [PMID: 34064859 DOI: 10.3390/ijms22105078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
99 Nason R, Jung JY, Chole RA. Lipopolysaccharide-induced osteoclastogenesis from mononuclear precursors: a mechanism for osteolysis in chronic otitis. J Assoc Res Otolaryngol. 2009;10:151-160. [PMID: 19145462 DOI: 10.1007/s10162-008-0153-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
100 Maurizi A, Rucci N. The Osteoclast in Bone Metastasis: Player and Target. Cancers (Basel) 2018;10:E218. [PMID: 29954079 DOI: 10.3390/cancers10070218] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 20.3] [Reference Citation Analysis]
101 Keupp K, Li Y, Vargel I, Hoischen A, Richardson R, Neveling K, Alanay Y, Uz E, Elcioğlu N, Rachwalski M, Kamaci S, Tunçbilek G, Akin B, Grötzinger J, Konas E, Mavili E, Müller-Newen G, Collmann H, Roscioli T, Buckley MF, Yigit G, Gilissen C, Kress W, Veltman J, Hammerschmidt M, Akarsu NA, Wollnik B. Mutations in the interleukin receptor IL11RA cause autosomal recessive Crouzon-like craniosynostosis. Mol Genet Genomic Med 2013;1:223-37. [PMID: 24498618 DOI: 10.1002/mgg3.28] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 6.1] [Reference Citation Analysis]
102 Guillou C, Fréret M, Fondard E, Derambure C, Avenel G, Golinski ML, Verdet M, Boyer O, Caillot F, Musette P, Lequerré T, Vittecoq O. Soluble alpha-enolase activates monocytes by CD14-dependent TLR4 signalling pathway and exhibits a dual function. Sci Rep 2016;6:23796. [PMID: 27025255 DOI: 10.1038/srep23796] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
103 Jung SM, Kim KW, Yang CW, Park SH, Ju JH. Cytokine-mediated bone destruction in rheumatoid arthritis. J Immunol Res 2014;2014:263625. [PMID: 25295284 DOI: 10.1155/2014/263625] [Cited by in Crossref: 72] [Cited by in F6Publishing: 77] [Article Influence: 10.3] [Reference Citation Analysis]
104 Haubruck P, Kammerer A, Korff S, Apitz P, Xiao K, Büchler A, Biglari B, Zimmermann G, Daniel V, Schmidmaier G, Moghaddam A. The treatment of nonunions with application of BMP-7 increases the expression pattern for angiogenic and inflammable cytokines: a matched pair analysis. J Inflamm Res 2016;9:155-65. [PMID: 27703392 DOI: 10.2147/JIR.S110621] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
105 He W, Wilder T, Cronstein BN. Rolofylline, an adenosine A1 receptor antagonist, inhibits osteoclast differentiation as an inverse agonist. Br J Pharmacol 2013;170:1167-76. [PMID: 23962057 DOI: 10.1111/bph.12342] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
106 Gnoni A, Brunetti O, Longo V, Calabrese A, Argentiero AL, Calbi R, Solimando Antonio G, Licchetta A. Immune system and bone microenvironment: rationale for targeted cancer therapies. Oncotarget 2020;11:480-7. [PMID: 32064051 DOI: 10.18632/oncotarget.27439] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
107 Burnham JM, Shults J, Dubner SE, Sembhi H, Zemel BS, Leonard MB. Bone density, structure, and strength in juvenile idiopathic arthritis: importance of disease severity and muscle deficits. Arthritis Rheum 2008;58:2518-27. [PMID: 18668565 DOI: 10.1002/art.23683] [Cited by in Crossref: 63] [Cited by in F6Publishing: 53] [Article Influence: 4.8] [Reference Citation Analysis]
108 Nieminen P, Morgan NV, Fenwick AL, Parmanen S, Veistinen L, Mikkola ML, van der Spek PJ, Giraud A, Judd L, Arte S, Brueton LA, Wall SA, Mathijssen IM, Maher ER, Wilkie AO, Kreiborg S, Thesleff I. Inactivation of IL11 signaling causes craniosynostosis, delayed tooth eruption, and supernumerary teeth. Am J Hum Genet 2011;89:67-81. [PMID: 21741611 DOI: 10.1016/j.ajhg.2011.05.024] [Cited by in F6Publishing: 105] [Reference Citation Analysis]
109 Virk MS, Lieberman JR. Tumor metastasis to bone. Arthritis Res Ther. 2007;9 Suppl 1:S5. [PMID: 17634144 DOI: 10.1186/ar2169] [Cited by in Crossref: 67] [Cited by in F6Publishing: 52] [Article Influence: 4.8] [Reference Citation Analysis]
110 Cao TQ, Phong NV, Kim JH, Gao D, Anh HLT, Ngo VD, Vinh LB, Koh YS, Yang SY. Inhibitory Effects of Cucurbitane-Type Triterpenoids from Momordica charantia Fruit on Lipopolysaccharide-Stimulated Pro-Inflammatory Cytokine Production in Bone Marrow-Derived Dendritic Cells. Molecules 2021;26:4444. [PMID: 34361596 DOI: 10.3390/molecules26154444] [Reference Citation Analysis]
111 Nakchbandi IA, Lang R, Kinder B, Insogna KL. The role of the receptor activator of nuclear factor-kappaB ligand/osteoprotegerin cytokine system in primary hyperparathyroidism. J Clin Endocrinol Metab. 2008;93:967-973. [PMID: 18073309 DOI: 10.1210/jc.2007-1645] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
112 Aielli F, Ponzetti M, Rucci N. Bone Metastasis Pain, from the Bench to the Bedside. Int J Mol Sci 2019;20:E280. [PMID: 30641973 DOI: 10.3390/ijms20020280] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
113 Cazalis J, Tanabe S, Gagnon G, Sorsa T, Grenier D. Tetracyclines and chemically modified tetracycline-3 (CMT-3) modulate cytokine secretion by lipopolysaccharide-stimulated whole blood. Inflammation 2009;32:130-7. [PMID: 19238528 DOI: 10.1007/s10753-009-9111-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
114 Kishimoto T. Interleukin-6: discovery of a pleiotropic cytokine. Arthritis Res Ther 2006;8 Suppl 2:S2. [PMID: 16899106 DOI: 10.1186/ar1916] [Cited by in Crossref: 271] [Cited by in F6Publishing: 277] [Article Influence: 18.1] [Reference Citation Analysis]
115 Smolen JS, Avila JC, Aletaha D. Tocilizumab inhibits progression of joint damage in rheumatoid arthritis irrespective of its anti-inflammatory effects: disassociation of the link between inflammation and destruction. Ann Rheum Dis 2012;71:687-93. [PMID: 22121130 DOI: 10.1136/annrheumdis-2011-200395] [Cited by in Crossref: 84] [Cited by in F6Publishing: 79] [Article Influence: 8.4] [Reference Citation Analysis]
116 Gabay C, Msihid J, Zilberstein M, Paccard C, Lin Y, Graham NMH, Boyapati A. Identification of sarilumab pharmacodynamic and predictive markers in patients with inadequate response to TNF inhibition: a biomarker substudy of the phase 3 TARGET study. RMD Open 2018;4:e000607. [PMID: 29556418 DOI: 10.1136/rmdopen-2017-000607] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
117 McCoy EM, Hong H, Pruitt HC, Feng X. IL-11 produced by breast cancer cells augments osteoclastogenesis by sustaining the pool of osteoclast progenitor cells. BMC Cancer 2013;13:16. [PMID: 23311882 DOI: 10.1186/1471-2407-13-16] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 5.1] [Reference Citation Analysis]
118 Ding LZ, Teng X, Zhang ZB, Zheng CJ, Chen SH. Mangiferin inhibits apoptosis and oxidative stress via BMP2/Smad-1 signaling in dexamethasone-induced MC3T3-E1 cells. Int J Mol Med 2018;41:2517-26. [PMID: 29484386 DOI: 10.3892/ijmm.2018.3506] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
119 Otero L, García DA, Wilches-Buitrago L. Expression and Presence of OPG and RANKL mRNA and Protein in Human Periodontal Ligament with Orthodontic Force. Gene Regul Syst Bio 2016;10:15-20. [PMID: 26823650 DOI: 10.4137/GRSB.S35368] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
120 Ramani VC, Yang Y, Ren Y, Nan L, Sanderson RD. Heparanase plays a dual role in driving hepatocyte growth factor (HGF) signaling by enhancing HGF expression and activity. J Biol Chem 2011;286:6490-9. [PMID: 21131364 DOI: 10.1074/jbc.M110.183277] [Cited by in Crossref: 87] [Cited by in F6Publishing: 58] [Article Influence: 7.9] [Reference Citation Analysis]
121 Guerrieri AN, Montesi M, Sprio S, Laranga R, Mercatali L, Tampieri A, Donati DM, Lucarelli E. Innovative Options for Bone Metastasis Treatment: An Extensive Analysis on Biomaterials-Based Strategies for Orthopedic Surgeons. Front Bioeng Biotechnol 2020;8:589964. [PMID: 33123519 DOI: 10.3389/fbioe.2020.589964] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
122 Lipsky PE. Interleukin-6 and rheumatic diseases. Arthritis Res Ther 2006;8 Suppl 2:S4. [PMID: 16899108 DOI: 10.1186/ar1918] [Cited by in Crossref: 66] [Cited by in F6Publishing: 70] [Article Influence: 4.4] [Reference Citation Analysis]
123 Tawara K, Oxford JT, Jorcyk CL. Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies. Cancer Manag Res. 2011;3:177-189. [PMID: 21625400 DOI: 10.2147/cmr.s18101] [Cited by in Crossref: 14] [Cited by in F6Publishing: 64] [Article Influence: 1.4] [Reference Citation Analysis]
124 Zheng Y, Basel D, Chow SO, Fong-Yee C, Kim S, Buttgereit F, Dunstan CR, Zhou H, Seibel MJ. Targeting IL-6 and RANKL signaling inhibits prostate cancer growth in bone. Clin Exp Metastasis 2014;31:921-33. [PMID: 25223386 DOI: 10.1007/s10585-014-9680-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 4.4] [Reference Citation Analysis]
125 Shin HS, Sarin R, Dixit N, Wu J, Gershwin E, Bowman EP, Adamopoulos IE. Crosstalk among IL-23 and DNAX activating protein of 12 kDa-dependent pathways promotes osteoclastogenesis. J Immunol 2015;194:316-24. [PMID: 25452564 DOI: 10.4049/jimmunol.1401013] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
126 Joseph J, Shiozawa Y, Jung Y, Kim JK, Pedersen E, Mishra A, Zalucha JL, Wang J, Keller ET, Pienta KJ, Taichman RS. Disseminated prostate cancer cells can instruct hematopoietic stem and progenitor cells to regulate bone phenotype. Mol Cancer Res 2012;10:282-92. [PMID: 22241219 DOI: 10.1158/1541-7786.MCR-11-0404] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]